newsfilter
← Latest News
GlobeNewswire·

LianBio Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Enrollment completed in registrational Phase 3 EXPLORER-CN trial of mavacamten, with data expected mid-2023Mavacamten patient education and physician awareness activities underway in China with inclusion in HCM treatment